Upstate Urology of Auburn now offers Aquablation therapy, a cutting-edge treatment for benign prostatic hyperplasia (BPH), marking a significant advancement in the region’s medical services. This innovative therapy, performed by the AquaBeam Robotic System, is the first FDA-approved, robotic-assisted procedure designed to treat lower urinary tract symptoms caused by an enlarged prostate. Utilizing real-time imaging and waterjet technology, it ensures precise removal of prostate tissue without heat, promising swift and controlled outcomes.
BPH is a common condition in men over 50, leading to uncomfortable urinary symptoms and potentially severe health issues if untreated. Unlike traditional surgical options, which often come with significant risks and side effects, Aquablation therapy offers a safer alternative with consistent results, regardless of prostate size or shape. This breakthrough could benefit half of all men between the ages of 51 and 60, along with an increasing number in older age groups.
Dr. Ryan Sidebottom of Upstate Urology of Auburn emphasized the therapy’s importance, stating, “Aquablation therapy is a significant step forward in our dedication to robotic surgery and improving men’s health. It offers effective symptom relief while minimizing the risk of sexual or urinary dysfunction.” This new therapy is expected to transform BPH treatment, offering hope and improved quality of life to many. For more information, patients can contact Upstate Urology of Auburn or visit the Aquablation website.
FingerLakes1.com is the region’s leading all-digital news publication. The company was founded in 1998 and has been keeping residents informed for more than two decades. Have a lead? Send it to [email protected].
Read the full article here
